GIP-A: Clinical Trials

4 trials of GIP-A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 4

Follow GIP-A: new trials by email Literature Review of GIP-A trials Research Report on GIP-A

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
GIP-A, Placebo - Acromegaly Due to Pituitary Adenoma
Not applicableCompletedUniversity of Copenhagen252019-08-132023-11-29
Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist
GIP-A, GLP-1 receptor antagonist Exendin[9-39], Placebo - Glucose Metabolism Disorders
Not applicableCompletedUniversity Hospital, Gentofte, Copenhagen182017-03-012017-11-01
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
GIP-A, Placebo, GLP-1 receptor antagonist Exendin[9-39] - Glucose Metabolism Disorders
Not applicableCompletedUniversity Hospital, Gentofte, Copenhagen122016-10-012019-06-04
GIP Receptor Antagonist Studies in Humans
GIP-A, GIP(1-42), Saline - Glucose Metabolism
Not applicableCompletedUniversity Hospital, Gentofte, Copenhagen102016-04-012017-04-27

Conditions studied

Glucose Metabolism Disorders (2)  ·  Growth Hormone-Secreting Pituitary Adenoma (1)

Sponsors

University Hospital, Gentofte, Copenhagen (3)  ·  University of Copenhagen (1)

Countries

Denmark (4)

Top investigators

Filip K Knop, MD, PhD (2)  ·  Fip K Knop, MD, PhD (1)  ·  Mette H Jensen, MSc (1)

Results publications

PMID 32730920, PMID 28948296, PMID 30626611, PMID 32077470